Middle East News Digest
SEE OTHER BRANDS

Your daily news update on the Middle East

Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on March 18, 2025

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration

BOSTON, March 18, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, and the Raymond A. Wood …

Critical One Announces Appointment of Award-Winning Geologist to Board of Directors

Critical One Announces Appointment of Award-Winning Geologist to Board of Directors

Chet Idziszek, Former Chief Geologist of Howells Lake Antimony Gold Project, Joins Team as Independent Director TORONTO, March 18, 2025 (GLOBE NEWSWIRE) -- Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL …

N2OFF Signs Non-Binding LOI for Potential 380MW Battery Energy Storage Projects

N2OFF Signs Non-Binding LOI for Potential 380MW Battery Energy Storage Projects

Neve Yarak, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech, have signed a non-binding letter of …

EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)

EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)

EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS) EBX-102-02 demonstrated clinically meaningful superiority over placebo in key efficacy assessments in patients …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service